Office of Research Message from the Vice Deans of Research Leadership & Staff Clinical Trials Administration Research Support & Development Biostatistical Resources Grant Support & Review Services NIH K and F Submissions Guide Training Grant Support NIH Resubmission Program NIH Resources NIH Boot Camp Physician Scientist Resources Guidance for Proposal Submissions Grant Incentive Programs and Pilot Awards Researcher Pipeline Policies and Guidelines Environmental Health and Safety Human Research Foreign Affiliations School Center Guidelines Space Allocation Vendor Event Policy Responsible Conduct of Research Rigor and Responsibility COVID-19 Response Funding Opportunities School of Medicine Funding Search Tool Faculty Research Retreat School of Medicine Funding Search Tool Home Research Office of Research School of Medicine Funding Search Tool Below is a curated, searchable and filterable list of funding opportunities announced by NIH in their weekly NIH guide LISTSERV. This list reflects funding opportunities pertinent to many UCI researchers. Using filters may reduce your results, so use judiciously. Opportunities are added weekly. You can sign up for the NIH guide listserv to receive a comprehensive list of funding opportunities every Friday. NIH Guide Listserv Search Funding Discipline - Any -Acute/Chronic PainAgingAlcoholism, Alcohol UseAlzheimer's/DementiaAmyotrophic lateral sclerosis (ALS)Artificial Intelligence/Machine LearningAutoimmune/ImmunologyBehavioral and Social ScienceBiomedical ImagingBiomedical TechnologyBrain DisordersCancerCancer GenomicsCannabinoid/CannabidiodCardiology/VascularCaregiving ResearchChronic ConditionsClimate ChangeClinical TrialsClinical/DiagnosticCoronaviruses/COVIDData Science/Software/DatabasesDiabetesDigestive/KidneyDissemination and Implementation ResearchDown SyndromeEarly career research awardEating DisordersEmergency CareEnvironmental healthEpilepsyEye Disease and Disorders of VisionFood AllergiesGene TherapyGenetic TestingGynecologyHealth Disparities/Social determinantsHealthcare deliveryHearing LossHematologyHIV/AIDSHuman GenomeHuntington's DiseaseInfectious Diseases/MicrobiologyLung/RespiratoryMedical EducationMental Health/IllnessMicrobiomeMusculoskeletal/SkinN/ANeurology/NeurodegenerativenoneNutritionObesityOrthopedicOtolaryngology-Head & Neck SurgeryPathologyPatient Care/SafetyPediatricPhysical ActivityPhysical RehabilitationPneumonia & InfluenzaPost-Traumatic Stress Disorder (PTSD)Precision MedicinePregnancy/Maternal Health/ObstetricsRadiation OncologyRare DiseasesRegenerative MedicineSepsisSickle Cell DiseaseSleepSpinal Cord InjuryStem Cell ResearchStrokeSubstance Abuse/AddictionSuicideSurgeryTelehealthTransplantationTraumatic Brain Injury (TBI)UrologyVaccine RelatedVector-Borne DiseasesViolenceWomenWound Healing and Care Date Range Min Max 2024 Deadline 3: Oct 05, 2024 Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional) (PAR-24-077) The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative observational and intervention-based research to identify and characterize the pathways and mechanisms through which health and health care disparities occur among sexual and gender minority populations of minoritized racial/ethnic and socio-economic statuses. National Institutes of Health (NIH) Federal Health Disparities/Social determinants HIV/AIDS Substance Abuse/Addiction 2024 Deadline 3: Oct 05, 2024 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) (PAR-24-072) Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. National Institutes of Health (NIH) Federal Cancer Clinical Trials 2024 Deadline 3: Oct 05, 2024 National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) (PAR-24-085) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is soliciting research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. National Institutes of Health (NIH) Federal Cancer Clinical Trials 2024 Deadline 3: Oct 05, 2024 Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) (PAR-24-088) The purpose of this Notice of Funding Opportunities (NOFOs) is to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds ( validated hits ) for chemical optimization and bioassays for testing new analog compounds. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Brain Disorders 2024 Deadline 2: Oct 05, 2024 New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) (PAR-24-160) The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Aging Cancer 2024 Deadline: Oct 08, 2024 Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional) The Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) program is designed to support integrated efforts of three to six PDs/PIs to pursue a bold, impactful, and challenging goal with defined 5-year outcomes within the scope of this program and the NINDS mission. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative 2024 Deadline 3: Oct 11, 2024 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) (RFA-MH-23-330) The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds, including those from underrepresented groups in the biomedical and behavioral sciences, in BRAIN Initiative research areas. National Institutes of Health (NIH) Federal Brain Disorders Early career research award Neurology/Neurodegenerative 2024 Deadline 3: Oct 11, 2024 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (RFA-MH-23-331) The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds, including those from underrepresented groups in the biomedical and behavioral sciences, in BRAIN Initiative research areas. National Institutes of Health (NIH) Federal Brain Disorders Early career research award Neurology/Neurodegenerative 2024 Deadline: Oct 11, 2024 NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) (PAR-23-198) The NIAID New Innovator Award supports postdoctoral and other candidates in non-independent positions or newly independent Early Stage Investigators of exceptional creativity who propose novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research of priority to NIAID. National Institutes of Health (NIH) Federal Early career research award 2024 Deadline 2: Oct 11, 2024 Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed) (PAR-23-222) The purpose of the Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00) program is to support promising, late-stage graduate students from diverse backgrounds, for example those from underrepresented groups (see Notice of NIH’s Interest in Diversity), to transition into and succeed in mentored postdoctoral research positions. National Institutes of Health (NIH) Federal Early career research award Pagination First page « First Previous page ‹‹ Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page ›› Last page Last »
2024 Deadline 3: Oct 05, 2024 Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional) (PAR-24-077) The purpose of this Notice of Funding Opportunity (NOFO) is to support innovative observational and intervention-based research to identify and characterize the pathways and mechanisms through which health and health care disparities occur among sexual and gender minority populations of minoritized racial/ethnic and socio-economic statuses. National Institutes of Health (NIH) Federal Health Disparities/Social determinants HIV/AIDS Substance Abuse/Addiction
2024 Deadline 3: Oct 05, 2024 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) (PAR-24-072) Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. National Institutes of Health (NIH) Federal Cancer Clinical Trials
2024 Deadline 3: Oct 05, 2024 National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) (PAR-24-085) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is soliciting research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. National Institutes of Health (NIH) Federal Cancer Clinical Trials
2024 Deadline 3: Oct 05, 2024 Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) (PAR-24-088) The purpose of this Notice of Funding Opportunities (NOFOs) is to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds ( validated hits ) for chemical optimization and bioassays for testing new analog compounds. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Brain Disorders
2024 Deadline 2: Oct 05, 2024 New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) (PAR-24-160) The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Aging Cancer
2024 Deadline: Oct 08, 2024 Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional) The Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) program is designed to support integrated efforts of three to six PDs/PIs to pursue a bold, impactful, and challenging goal with defined 5-year outcomes within the scope of this program and the NINDS mission. National Institutes of Health (NIH) Federal Neurology/Neurodegenerative
2024 Deadline 3: Oct 11, 2024 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) (RFA-MH-23-330) The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds, including those from underrepresented groups in the biomedical and behavioral sciences, in BRAIN Initiative research areas. National Institutes of Health (NIH) Federal Brain Disorders Early career research award Neurology/Neurodegenerative
2024 Deadline 3: Oct 11, 2024 BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (RFA-MH-23-331) The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds, including those from underrepresented groups in the biomedical and behavioral sciences, in BRAIN Initiative research areas. National Institutes of Health (NIH) Federal Brain Disorders Early career research award Neurology/Neurodegenerative
2024 Deadline: Oct 11, 2024 NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) (PAR-23-198) The NIAID New Innovator Award supports postdoctoral and other candidates in non-independent positions or newly independent Early Stage Investigators of exceptional creativity who propose novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research of priority to NIAID. National Institutes of Health (NIH) Federal Early career research award
2024 Deadline 2: Oct 11, 2024 Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed) (PAR-23-222) The purpose of the Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00) program is to support promising, late-stage graduate students from diverse backgrounds, for example those from underrepresented groups (see Notice of NIH’s Interest in Diversity), to transition into and succeed in mentored postdoctoral research positions. National Institutes of Health (NIH) Federal Early career research award